ARCALIS, Inc.

ARCALIS is a CDMO specializing in messenger RNA (mRNA) Medicines & Vaccines. Founded as a joint venture between Axcelead, Inc., Japan’s first drug discovery platform company, and Arcturus Therapeutics, a US-based clinical mRNA medicines company.In July 2023, ARCALIS established a GMP mRNA drug substance manufacturing facility in Japan, further strengthening our capabilities. In 2024, we achieved a significant milestone with the world's first commercial production of a self-amplifying mRNA vaccine against COVID-19.mRNA technology is driving innovation be...